Association between the clinical-functional parameters and lipid markers of systemic inflammation in mild asthma complicated with obesity

   Aim. To identify the features of the association between the clinical-functional conditions and lipid markers of systemic inflammation (fatty acids, eicosanoids, plasmalogens) of patients with mild asthma and obesity.

   Materials and methods. Obese (n=80) and nonobese (n = 55) adults with mild, partially controlled asthma aged 28 to 65 years, and nonobese (n = 30) healthy controls had venous blood samples analysed. The ACQ-5 test, spirometry were evaluated. Serum thromboxane B2 (ТХВ2) and leukotriene B4 (LTB4) were analyzed by the enzyme immunoassay method. Fatty acids
as methyl esters (FAMEs) and plasmalogens in the form of dimethyl acetals (DMA) were estimated in blood plasma by gas chromatography-mass spectrometry.

   Results. In obese patients with asthma, the ACQ-5 test was lower in comparison to nonobese patients. FEV1 decreased by 8 %, FVC by 12% (p < 0.05). A decrease in the level of DMA16: 0 by 17.5 % and DMA18: 0 by 25 % was established in obese asthma patients. The ratio of DMA16:0/FAME 16: 0 declined by 21 %, DMA18:0/FAME18: 0 − by 28 %. A fall in eicosapentaenoic acid (20: 5n3) and a change in the 20:4n6/20:5n3 ratio were found. The level of ТХВ2 and LTB4 was increased regardless of body weight. There was a positive correlation between body mass index and levels of LTB4 (r = 0.46), ТХВ2 (r = 0.49); and a negative correlation between ACQ and ТХВ2 (r = - 0.58). Indicators of lung function (FEV1, FVC, VC) had correlative links with DMA18:0, DMA20:0, eicosapentaenoic acid.

   Conclusion. We showed the change in the inflammatory fatty acids and eicosanoids synthesis and plasmalogen deficiency in obese-asthma. Established relationships between clinical and functional parameters and lipid markers of systemic inflammation, plasmalogen deficiency in patients with asthma and obesity reveal new pathogenetic mechanisms of the systemic inflammatory process in chronic respiratory diseases.

1. Leontieva N. M., Demko I. V., Sobko E. A., Ischenko O. P. [Clinical and diagnostic features of mild asthma]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2020; (77):99–106 (in Russian). https://doi.org/10.36604/1998-5029-2020-77-99-106

2. Leontieva N. M., Demko I. V., Sobko E. A., Soloveva I. A., Kraposhina A. Yu., Gordeeva N. V. [Mild bronchial asthma: diagnostic problems and possibility of functional examination methods]. Siberian Medical Review 2020; (1):5–13 (in Russian). https://doi.org/10.20333/2500136-2020-1-5-13

3. Avdeev S. N., Aisanov Z. R., Belevskiy A. S., Kulbaisov A. M., Kurbacheva O. M., Leshchenko I. V., Nenasheva N. M., Fassakhov R. S. [Mild bronchial asthma: the present and the future]. Pulmonologiya 2018; 28(1):84–95 (in Russian). https://doi.org/10.18093/0869-0189-2018-28-1-84-95

4. Olaguibel J. M., Quirce S., Juliá B., Fernández C., Fortuna A. M., Molina J., Plaza V. Measurement of asthma control according to Global Initiative for Asthma guidelines: a comparison with the Asthma Control Questionnaire. Respir. Res. 2012; 13 (1): 50. https://doi.org/10.1186/1465-9921-13-50

5. Nenasheva N. M. [Biological therapy of asthma: present and future]. Consilium Medicum 2016; 18 (11): 30–38 (in Russian).

6. Karateev A. E., Aleinikova T. L. [Eicosanoids and inflammation]. Modern Rheumatology Journal 2016; 10 (4): 73–86 (in Russian). https://doi.org/10.14412/1996-7012-2016-4-73-86

7. Polyakova S. I., Zasurtsev G. V., Parshina P. V., Kobrinskiy B. A. [Prospects for the diagnosis and treatment of plasmalogen deficiency]. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66 (4): 16–24 (in Russian). https://doi.org/10.21508/1027-4065-2021-66-4-16-24

8. Sordillo J. E., Lutz S. M., Kelly R. S., McGeachie M. J., Dahlin A., Tantisira K., Clish C., Lasky-Su J. Wu A. C. Plasmalogens Mediate the Effect of Age on Bronchodilator Response in Individuals With Asthma. Front. Med. 2020; 7 (38): 1–3. https://doi.org/10.3389/fmed.2020.00038

9. Yamazaki Y., Kondo K., Maeba R., Nishimukai M., Nezu T., Hara H. The proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome. J. Oleo Sci. 2014; 63 (5): 527–537. https://doi.org/10.5650/jos.ess13226

10. Bligh E. G., Dyer W. J. A rapid method of total lipid extraction and purification // Can. J. Biochem. Physiol. 1959. Vol.37, Iss.8. P. 911−917. https://doi.org/10.1139/o59-099

11. Carreau J. P., Dubacq J. P. Adaptation of a macro-scale method to the micro-scale for fatty acid methyl transesterification of biological lipid extract. J. Chromatogr. 1978; 151 (3): 384−390. https://doi.org/10.1016/S0021-9673(00)88356-9

12. Grainge C. L., Davies D. E. Epithelial injury and repair in airways diseases. Chest 2013; 144 (6): 1906–1912. https://doi.org/10.1378/chest.12-1944